Adam Abbas
PHILADELPHIA—There is little evidence to show an increased risk for aspiration pneumonia or other pulmonary complications in surgical patients taking glucagon-like peptide-1 GLP-1 receptor agonists, according to a pair of studies presented at the 2024 annual meeting of the American Society of Anesthesiologists.
“Over the past few years, data have started to emerge regarding the potential for aspiration events in endoscopic patients taking GLP-1 agonists due to the risk of